Brokerages Set Integer Holdings Corporation (NYSE:ITGR) PT at $145.00

Shares of Integer Holdings Corporation (NYSE:ITGR - Get Free Report) have been assigned an average rating of "Buy" from the nine brokerages that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation, seven have assigned a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price target among analysts that have covered the stock in the last year is $145.00.

Several equities analysts have issued reports on the company. KeyCorp dropped their price objective on Integer from $154.00 to $145.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Citigroup raised Integer from a "hold" rating to a "strong-buy" rating and raised their price objective for the stock from $133.00 to $140.00 in a report on Thursday, May 22nd. Raymond James Financial increased their target price on shares of Integer from $145.00 to $150.00 and gave the stock an "outperform" rating in a research note on Friday, April 25th. Truist Financial set a $150.00 target price on shares of Integer and gave the stock a "buy" rating in a research note on Friday, April 25th. Finally, Wall Street Zen upgraded shares of Integer from a "sell" rating to a "hold" rating in a research note on Monday, May 19th.

Insider Activity at Integer

In other Integer news, CEO Joseph W. Dziedzic sold 338,975 shares of the stock in a transaction dated Thursday, May 1st. The shares were sold at an average price of $123.17, for a total value of $41,751,550.75. Following the completion of the transaction, the chief executive officer now directly owns 47,000 shares of the company's stock, valued at approximately $5,788,990. This trade represents a 87.82% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Martin C. Maxwell sold 8,720 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $120.56, for a total transaction of $1,051,283.20. Following the completion of the transaction, the director now directly owns 22,170 shares of the company's stock, valued at approximately $2,672,815.20. This trade represents a 28.23% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 362,434 shares of company stock worth $44,577,115 over the last 90 days. Company insiders own 2.16% of the company's stock.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in ITGR. Raymond James Financial Inc. purchased a new position in shares of Integer during the 4th quarter worth approximately $38,073,000. Vaughan Nelson Investment Management L.P. purchased a new position in shares of Integer during the 1st quarter worth approximately $33,337,000. Capital Research Global Investors increased its stake in shares of Integer by 16.0% during the 4th quarter. Capital Research Global Investors now owns 1,410,803 shares of the medical equipment provider's stock worth $186,960,000 after purchasing an additional 194,895 shares in the last quarter. Artisan Partners Limited Partnership purchased a new position in shares of Integer during the 4th quarter worth approximately $22,775,000. Finally, Nuveen LLC purchased a new position in shares of Integer during the 1st quarter worth approximately $17,634,000. 99.29% of the stock is owned by hedge funds and other institutional investors.

Integer Stock Up 1.1%

NYSE:ITGR traded up $1.26 during trading hours on Friday, hitting $119.06. The company's stock had a trading volume of 399,185 shares, compared to its average volume of 380,722. The stock has a market capitalization of $4.15 billion, a P/E ratio of 56.43, a price-to-earnings-growth ratio of 1.01 and a beta of 0.98. The stock has a fifty day moving average of $119.90 and a 200-day moving average of $126.59. The company has a current ratio of 3.40, a quick ratio of 2.14 and a debt-to-equity ratio of 0.78. Integer has a 52-week low of $104.93 and a 52-week high of $146.36.

Integer (NYSE:ITGR - Get Free Report) last posted its earnings results on Thursday, April 24th. The medical equipment provider reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $437.39 million for the quarter, compared to analyst estimates of $428.51 million. Integer had a return on equity of 11.95% and a net margin of 4.38%. Integer's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.14 earnings per share. On average, equities analysts forecast that Integer will post 6.01 earnings per share for the current year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.